Acquisition

IPC Systems' new NYC hub isn't just a lease. It's a strategic bet on physical proximity as the core of resilient, innovative financial technology.

Maker's Mark's new partnership with the player-owned Unrivaled league is more than a sponsorship; it's a strategic bet on the future of sports.

BDO USA's launch of a new government unit isn't just a merger. It's a strategic play to dominate the high-stakes world of public sector recovery.

Facing federal overhaul and public outcry, top organizations pledge reform. Can innovation and transparency fix a broken system and save thousands of lives?

With its 2026 Investor Day nearing, PHINIA aims to prove its dual-path strategy is the key to powering a diverse, carbon-conscious industrial future.

Secure identity firm CLEAR lands a major CMS contract to overhaul Medicare.gov's login system, signaling a strategic push into the government sector.

Eli Lilly's takeover of Adverum signals a major push into ocular gene therapy. Can a one-time injection for vision loss disrupt a multi-billion dollar market?

Beyond a simple product launch, a strategic acquisition is fueling innovations in drug delivery that could transform patient care for millions worldwide.

A new partnership aims to fix the broken music industry with a global commerce engine and advanced AI, giving artists true ownership of their careers.

Century Therapeutics adds M&A and investment heavyweights to its board, a strategic move to navigate the clinical gauntlet with its iPSC-derived diabetes cure.

A top FinTech firm's new product chief reveals a strategic roadmap for taming complexity that the defense and space sectors cannot afford to ignore.

A mandatory disclosure from a Boston investment giant reveals its position in a $1.4B merger. What does it signal for the future of the auto industry?

A French bank's cryptic filing on UK's Just Group reveals a high-stakes hedging strategy amid a major takeover. What does it really signal for the deal?

A fierce bidding war for Avadel Pharmaceuticals reveals the high value of its key drug, as filings from giants like State Street highlight M&A transparency.

Wealth Enhancement's $2.2B deal for L.M. Kohn isn't just another acquisition. It signals a tech-fueled consolidation wave reshaping financial advice.

Aviz Networks just launched a certified SONiC distribution, aiming to break down the barriers of complexity and support that have kept open networking on the sidelines.

Target RWE's strategic hire of NoviSci co-founder Alan Brookhart signals a major push to master regulatory-grade real-world evidence. What does this mean?

Groundbreaking lymphoma data and a strategic acquisition position Natera to dominate the liquid biopsy market, challenging old standards and creating new value.

Beyond the award, Pariveda's use of generative AI to modernize legacy systems reveals a powerful new playbook for enterprise transformation and value.

A landmark private equity deal in Europe's produce sector is about more than money; it's a strategic move to build a resilient food supply chain.